Clinical trial
Allo BMT in Advanced Leukemia or High Grade Lymphoma
NCT00186290 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186290 |
|---|---|
| Title | Allo BMT in Advanced Leukemia or High Grade Lymphoma |
| Official title | Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, Leukemia, Blood and Marrow Transplant (BMT), Lymphomas: Non-Hodgkin |
| Intervention type | Procedure |
| Interventions | ablative allogeneic hematopoietic cell transplantation |
| Enrollment | 145 |
| Start date | Dec 1, 1989 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: